Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
Many technology-driven interventions entail considerable financial cost, raising affordability issues. The implantable cardioverter defibrillator (ICD) is a case of an effective primary prevention intervention with high initial costs that is capable of delivering long-term population benefits. At first glance, such interventions may provoke diffidence, if not active resistance, due to the financial burdens which inevitably accompany their widespread adoption. In this article, we review the available economic tools that can help address the ICD cost issue. We think awareness of such knowledge may facilitate dialogues between physicians, administrators and policymakers, and help foster rational decision-making.
Boriani
G
G
Institute of Cardiology, University of Bologna, Bologna, Italy. giuseppe.boriani@unibo.it
Biffi
M
M
Martignani
C
C
Diemberger
I
I
Valzania
C
C
Bertini
M
M
Branzi
A
A
D003362:Cost-Benefit Analysis; D017147:Defibrillators, Implantable / Q000191:economics*; D019317:Evidence-Based Medicine / Q000191:economics; D017048:Health Care Costs; D006333:Heart Failure / Q000517:prevention & control*; D006801:Humans